NDC 63459-0700 - AMRIX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63459-0700
- Manufacturer
- Rebel Distributors Corp.
- Effective date
- 2010-09-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMRIX ® (Cyclobenzaprine Hydrochloride Extended-Release Capsules) | Rebel Distributors Corp. | 2010-09-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nu Colour Bioadaptive BB Plus Foundation - Light Golden | TITANIUM DIOXIDE | NSE Products, Inc. | faae6f47-19f3-41cb-8e0d-388569b5c73d | 2026-04-07 | Warnings | 15FIX9V2JP |
| Ultra Sunscreen | OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE | Jiangsu Senwo Medical Technology Co., Ltd. | 4ed974b8-6c11-08e0-e063-6294a90a7713 | 2026-04-07 | Warnings | 15FIX9V2JP |
| Neutrogena MINERAL UV TINT FACE MEDIUM DEEP SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Acupac Packaging, Inc | 4ee39bbf-b7d7-8f87-e063-6294a90a2539 | 2026-04-07 | Warnings | 15FIX9V2JP |
| Nu Colour Bioadaptive BB plus Foundation - Beige | TITANIUM DIOXIDE | NSE Products, Inc. | f74e83fe-41a0-4998-ae53-30ed5af47592 | 2026-04-07 | Warnings | 15FIX9V2JP |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 2f89c8f6-7f3c-8396-e063-6294a90a643e | 2026-04-06 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Sportpharm LLC | 24653b10-bdf0-47c5-a1f4-dc25f3b86032 | 2026-04-03 | Warnings, Adverse reactions | 0VE05JYS2P |
| EltaMD Skincare UV AOX Elements SPF50 Tinted | TITANIUM DIOXIDE, ZINC OXIDE SUNSCREEN | CP Skin Health Group, Inc | 2c74209d-9b88-4c32-ad42-cd6de16c1fef | 2026-04-03 | Warnings | 15FIX9V2JP |
| EltaMD UV Restore Tinted | TITANIUM DIOXIDE AND ZINC OXIDE SUNSCREEN | CP Skin Health Group, Inc | 4fc18856-01b3-43ed-9e1b-b4394e31aa3c | 2026-04-03 | Warnings | 15FIX9V2JP |
| Sunscreen for baby SPF50plus | OCTOCRYLENE,ETHYLHEXYL METHOXYCINNAMATE,TITANIUM DIOXIDE,ETHYLHEXYL SALICYLATE | Guangzhou Senmai Biotechnology Co., Ltd. | 1cb7fbca-0874-ae53-e063-6294a90ab42a | 2026-04-02 | Warnings | 15FIX9V2JP |
| TiZO3 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | 4e7bdec2-abcc-0267-e063-6394a90ae47a | 2026-04-02 | Warnings | 15FIX9V2JP |
| EltaMD UV Restore | TITANIUM DIOXIDE, ZINC OXIDE SUNSCREEN | CP Skin Health Group, Inc | 17b47994-82d6-4f9d-8249-bdb55106c9b3 | 2026-04-02 | Warnings | 15FIX9V2JP |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 348c7ad4-b380-4b78-88f4-106b94079f52 | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Clinical Skin Filter Tinted Sunscreen | CLINICAL SKIN FILTER TINTED SUNSCREEN | BY KIN AESTHETICS LLC | 4e69a8a3-8dbb-577a-e063-6294a90a6a23 | 2026-04-01 | Warnings | 15FIX9V2JP |
| Krx Aesthetics All Day Glow Sunblocker | KRX AESTHETICS ALL DAY GLOW SUNBLOCKER | BY KIN AESTHETICS LLC | 4e69df43-393b-bc09-e063-6394a90a275a | 2026-04-01 | Warnings | 15FIX9V2JP |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e4e8bab3-c5e7-4d2b-9692-ee6c6799b120 | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 014dd648-5b84-4d1d-80fc-a467e2d741ef | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ac8ae965-af50-41d3-8df5-ca6daf4bbd1c | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e343fd12-1ca2-418a-b690-f3e8f567596d | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 29ca9548-23b0-4c50-82cb-4f0564d7e065 | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | a4cc7965-2ba8-42e8-8c5c-b90145a6598a | 2026-04-01 | Warnings, Adverse reactions | 0VE05JYS2P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.